Guardian Pharmacy VP David Norman Martin sells 5K shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Guardian Pharmacy Services, Inc. (GRDN) reports that its Senior Vice President, Technology, Data & Senior Security Officer, David Norman Martin, sold 4,800 Class A shares at a weighted average price of $50.24 and 200 shares at a weighted average price of $50.58 on November 17, 2026. Both sales were made under a Rule 10b5-1(c) trading plan adopted August 18, 2026.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock F1, F2 | 4,800 | $50.24 | $241K |
| Sale | Class A Common Stock F1, F3 | 200 | $50.58 | $10K |
Footnotes (3)
- F1. This Form 4/A is being filed to check the box to indicate that the transactions reported herein were effected pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on August 18, 2026.
- F2. The price reported in Column 4 is a weighted average price. These shares of Class A common stock, par value $0.001 per share ("Common Stock"), of Guardian Pharmacy Services, Inc. (the "Issuer") were sold in multiple transactions at prices ranging from $49.57 to $50.56, inclusive. The reporting persons undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in Footnote 2 to this Form 4.
- F3. The price reported in Column 4 is a weighted average price. These shares of Common Stock of the Issuer were sold in multiple transactions at prices ranging from $50.57 to $50.59, inclusive. The reporting persons undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in Footnote 3 to this Form 4.
Key Figures
Key Terms
Rule 10b5-1(c) trading plan regulatory
weighted average price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.